Robert D. Schreiber

108.8k citations
385 papers · 79.6k indexed · 37 hit papers · h-index 119

Impact in

  • Immunology top 0.01%
    • Immunotherapy and Immune Responses
    • Immune Cell Function and Interaction
    • T-cell and B-cell Immunology
    • interferon and immune responses
    • Immune Response and Inflammation
  • Oncology top 0.01%
    • Cancer Immunotherapy and Biomarkers
    • Cytokine Signaling Pathways and Interactions
    • CAR-T cell therapy research

Papers in

    • Immune Cell Function and Interaction 88
    • Immunotherapy and Immune Responses 76
    • Immune Response and Inflammation 60
    • T-cell and B-cell Immunology 48
    • interferon and immune responses 41
    • Cytokine Signaling Pathways and Interactions 61
    • Cancer Immunotherapy and Biomarkers 34

Robert D. Schreiber

376 papers receiving 77.6k citations

Hit Papers

cDC1 prime and are licensed by CD4+ T cells to induce anti-tumour immunity 2020 · 356 citations
356197720261993200910002.0k3.0k4.0k

Peers

Robert D. Schreiber
Comparison fields: 5 of 177
  • Immunology 48.3k
  • Oncology 33.6k
  • Cancer Research 7.5k
  • Molecular Biology 20.7k
  • Parasitology 1.8k
Replace Hideo Yagita∥ with:
Hideo Yagita∥ Japan
Arlene H. Sharpe United States
Gordon J. Freeman United States
Tadatsugu Taniguchi Japan
Nico van Rooijen Netherlands
Mark J. Smyth Australia
Vijay K. Kuchroo United States
Giorgio Trinchieri United States
Tak W. Mak Canada
Vishva M. Dixit United States
Robert D. Schreiber relative to Hideo Yagita∥ Japan Hideo Yagita∥'s profile →
Citations per field
00.5×3.1×
Hideo Yagita∥ · 1×
Citations per year

Countries citing papers authored by Robert D. Schreiber

Since Specialization
Citations

This map shows the geographic impact of Robert D. Schreiber's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert D. Schreiber with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert D. Schreiber more than expected).

Fields of papers citing papers by Robert D. Schreiber

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert D. Schreiber. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert D. Schreiber. The network helps show where Robert D. Schreiber may publish in the future.

Co-authors

The 25 scholars most cited alongside Robert D. Schreiber, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Robert D. Schreiber Line = papers co-authored together Robert D. Schreiber links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 202427
2 20241
3 20230
4 20220
5 202193
6 2017242
7 201680
8
Persistent LCMV Infection Is Controlled by Blockade of Type I Interferon Signaling
Hit paper breakdown →
2013583
9 2012257
10 201288
11 201222
12 201132
13 201087
14 200970
15
Batf3 Deficiency Reveals a Critical Role for CD8α + Dendritic Cells in Cytotoxic T Cell Immunity
Hit paper breakdown →
20081543
16 2008244
17 200656
18 2001374
19 1997282
20
Frauenverbände und Frauenvereinigungen in der Bundesrepublik Deutschland
19942

About Robert D. Schreiber

Robert D. Schreiber is a scholar working on Immunology, Oncology, Hematology, Radiology, Nuclear Medicine and Imaging and Cellular and Molecular Neuroscience, having authored 385 papers that have together received 79.6k indexed citations. Recurring topics across this work include Immune Cell Function and Interaction (88 papers), Immunotherapy and Immune Responses (76 papers), Cytokine Signaling Pathways and Interactions (61 papers), Immune Response and Inflammation (60 papers), T-cell and B-cell Immunology (48 papers), Monoclonal and Polyclonal Antibodies Research (45 papers), interferon and immune responses (41 papers) and Cancer Immunotherapy and Biomarkers (34 papers). The work is most often cited by research in Immunology (48.3k citations), Oncology (33.6k citations), Cancer Research (7.5k citations), Molecular Biology (20.7k citations) and Parasitology (1.8k citations). Robert D. Schreiber has collaborated with scholars based in United States, Germany and France. Frequent co-authors include Lloyd J. Old, Gavin P. Dunn, Mark J. Smyth, Ton N. Schumacher, Hiroaki Ikeda, Allen T. Bruce, Hans J. Müller‐Eberhard, Kathleen C. F. Sheehan, George R. Stark and Michael A. Farrar. Their work appears in journals such as The Journal of Immunology, The Journal of Experimental Medicine, Proceedings of the National Academy of Sciences, Behavioural Pharmacology and Journal of Biological Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026